Voleon Capital Management »

Theravance Biopharma shares owned by Voleon Capital Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Voleon Capital Management from 13F filings

Historical chart of Voleon Capital Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Voleon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Voleon Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $331k 20k 17.00

More positions owned by Voleon Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Micron Technology (MU)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Sandisk Corp (SNDK)
Eli Lilly & Co. (LLY)
Intel Corporation (INTC)
Astera Labs (ALAB)

View all positions for Voleon Capital Management

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
BlackRock
Newtyn Management
Irenic Capital Management
Vanguard Capital Management
State Street Corporation
Two Sigma Investments
D. E. Shaw & Co
Acadian Asset Management
Geode Capital Management
Dimensional Fund Advisors
Mackenzie Financial
Oasis Management
Citadel Advisors

View all funds holding Theravance Biopharma